Coherus Oncology, Inc. (CHRS) Earnings
NASDAQ·Healthcare·Biotechnology
$1.40
-2.78%
Mkt Cap $175.05M
EPS — Estimate vs Actual
Mkt Cap
$175.05M
P/E
1.27
Fwd P/E
—
P/S
3.73
Rev TTM
—
EPS TTM
-$1.28
NASDAQ·Healthcare·Biotechnology
$1.40
-2.78%
Mkt Cap $175.05M
Mkt Cap
$175.05M
P/E
1.27
Fwd P/E
—
P/S
3.73
Rev TTM
—
EPS TTM
-$1.28